Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

There will be scheduled maintenance work beginning on Saturday 15th June 2019 at 8:30 am through to Sunday 16th June 2019 at 11:30 pm (BST).

During this time our website may be temporarily affected. We apologise for any inconvenience this might cause and thank you for your patience.


Issue 49, 2015
Previous Article Next Article

Coumarins as privileged scaffold for anti-inflammatory drug development

Author affiliations

Abstract

Several literature reports had highlighted the significance of coumarin nucleus as a source of potential candidates for anti-inflammatory drug development. Various natural coumarins such as umbelliferone, scopoletin, visnadin, marmin and esculetin demonstrated potent anti-inflammatory activity through various mechanisms. Keeping in view the importance of naturally occurring coumarins, researchers have extensively explored these by synthesizing various derivatives as anti-inflammatory agents. The present review describes different synthetic modifications carried out on coumarin nucleus, assessment of their anti-inflammatory potential and structure–activity relationship (SAR) study, reported during 1992–2014. SAR may help medicinal chemists in rational design of future anti-inflammatory molecules based on coumarin scaffold.

Graphical abstract: Coumarins as privileged scaffold for anti-inflammatory drug development

Back to tab navigation

Publication details

The article was received on 30 Mar 2015, accepted on 20 Apr 2015 and first published on 20 Apr 2015


Article type: Review Article
DOI: 10.1039/C5RA05643H
RSC Adv., 2015,5, 38892-38905

  •   Request permissions

    Coumarins as privileged scaffold for anti-inflammatory drug development

    J. Grover and S. M. Jachak, RSC Adv., 2015, 5, 38892
    DOI: 10.1039/C5RA05643H

Search articles by author

Spotlight

Advertisements